Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 158


The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells.

Kuzmin I, Gillespie JW, Protopopov A, Geil L, Dreijerink K, Yang Y, Vocke CD, Duh FM, Zabarovsky E, Minna JD, Rhim JS, Emmert-Buck MR, Linehan WM, Lerman MI.

Cancer Res. 2002 Jun 15;62(12):3498-502.


Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.

Lee MG, Kim HY, Byun DS, Lee SJ, Lee CH, Kim JI, Chang SG, Chi SG.

Cancer Res. 2001 Sep 15;61(18):6688-92.


Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines.

Harada K, Toyooka S, Maitra A, Maruyama R, Toyooka KO, Timmons CF, Tomlinson GE, Mastrangelo D, Hay RJ, Minna JD, Gazdar AF.

Oncogene. 2002 Jun 20;21(27):4345-9.


Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.

Schagdarsurengin U, Gimm O, Hoang-Vu C, Dralle H, Pfeifer GP, Dammann R.

Cancer Res. 2002 Jul 1;62(13):3698-701.


Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection.

Kuzmin I, Liu L, Dammann R, Geil L, Stanbridge EJ, Wilczynski SP, Lerman MI, Pfeifer GP.

Cancer Res. 2003 Apr 15;63(8):1888-93.


Frequent hypermethylation of the RASSF1A gene in prostate cancer.

Liu L, Yoon JH, Dammann R, Pfeifer GP.

Oncogene. 2002 Oct 3;21(44):6835-40.


High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.

Zhang YJ, Ahsan H, Chen Y, Lunn RM, Wang LY, Chen SY, Lee PH, Chen CJ, Santella RM.

Mol Carcinog. 2002 Oct;35(2):85-92.


A novel human cancer culture model for the study of prostate cancer.

Yasunaga Y, Nakamura K, Ko D, Srivastava S, Moul JW, Sesterhenn IA, McLeod DG, Rhim JS.

Oncogene. 2001 Nov 29;20(55):8036-41.


Frequent hypermethylation of promoter region of RASSF1A in tumor tissues and voided urine of urinary bladder cancer patients.

Chan MW, Chan LW, Tang NL, Lo KW, Tong JH, Chan AW, Cheung HY, Wong WS, Chan PS, Lai FM, To KF.

Int J Cancer. 2003 May 1;104(5):611-6.


Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma.

Yang Q, Zage P, Kagan D, Tian Y, Seshadri R, Salwen HR, Liu S, Chlenski A, Cohn SL.

Clin Cancer Res. 2004 Dec 15;10(24):8493-500.


Epigenetic modifications of RASSF1A gene through chromatin remodeling in prostate cancer.

Kawamoto K, Okino ST, Place RF, Urakami S, Hirata H, Kikuno N, Kawakami T, Tanaka Y, Pookot D, Chen Z, Majid S, Enokida H, Nakagawa M, Dahiya R.

Clin Cancer Res. 2007 May 1;13(9):2541-8.


Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.

Spugnardi M, Tommasi S, Dammann R, Pfeifer GP, Hoon DS.

Cancer Res. 2003 Apr 1;63(7):1639-43.


[Methylation of the RASSF1A tumor suppressor gene promoter. Risk factor for carcinogenesis of urological tumors].

Serth J, Tezval H, Peters I, Atschekzei F, Rehmet K, Jurk S, Albrecht K, Kuczyk MA, Merseburger AS.

Urologe A. 2008 Sep;47(9):1117-8, 1120-1. doi: 10.1007/s00120-008-1821-3. German.


Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma.

Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Mori M, Croce CM.

Clin Cancer Res. 2003 Apr;9(4):1441-5.


Gene promoter methylation in prostate tumor-associated stromal cells.

Hanson JA, Gillespie JW, Grover A, Tangrea MA, Chuaqui RF, Emmert-Buck MR, Tangrea JA, Libutti SK, Linehan WM, Woodson KG.

J Natl Cancer Inst. 2006 Feb 15;98(4):255-61.


Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.

Agathanggelou A, Dallol A, Zöchbauer-Müller S, Morrissey C, Honorio S, Hesson L, Martinsson T, Fong KM, Kuo MJ, Yuen PW, Maher ER, Minna JD, Latif F.

Oncogene. 2003 Mar 13;22(10):1580-8.


Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma.

Murray PG, Qiu GH, Fu L, Waites ER, Srivastava G, Heys D, Agathanggelou A, Latif F, Grundy RG, Mann JR, Starczynski J, Crocker J, Parkes SE, Ambinder RF, Young LS, Tao Q.

Oncogene. 2004 Feb 12;23(6):1326-31.


Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.

Wong ML, Tao Q, Fu L, Wong KY, Qiu GH, Law FB, Tin PC, Cheung WL, Lee PY, Tang JC, Tsao GS, Lam KY, Law S, Wong J, Srivastava G.

Int J Oncol. 2006 Mar;28(3):767-73.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk